Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank 144a Regulatory News (AXBA)

Share Price Information for Axis Bank 144a (AXBA)

Share Price is delayed by 15 minutes
Get Live Data
40.9145    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $25.45b
AXBA Live PriceLast checked at - London Stock Exchange

Intraday Axis Bank 144a Share Chart

ESOP Grant

16 Jul 2025 09:38

RNS Number : 2977R
Axis Bank Limited
16 July 2025
 

AXIS/CO/CS/171/2025-26

 

July 16, 2025

 

National Stock Exchange of India Limited

Exchange Plaza, 5th Floor

Plot No. C/1, "G" Block

Bandra-Kurla Complex

Bandra (E), Mumbai - 400 051

 

NSE Symbol: AXISBANK

BSE Limited

1st Floor,

P. J. Towers,

Dalal Street

Fort, Mumbai - 400 001

 

BSE Scrip Code: 532215

 

Dear Sir/Madam,

 

REF.:

DISCLOSURE UNDER REGULATION 30 OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015

SUB.:

GRANT OF STOCK OPTIONS/UNITS

 

This is to inform you that the Nomination and Remuneration Committee at its meeting held today i.e., July 16, 2025, has granted 1,37,575 stock options at an exercise price of Rs. 1,165.90/- per option under the Axis Bank Employees Stock Option Scheme 2000-01 to the eligible employees of the Bank.

 

Disclosures as required under SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, is enclosed as Annexure A.

 

The meeting commenced at 10.30 am (IST) and concluded at 1:40 pm (IST).

 

This is for your information and records.

 

Yours faithfully,

 

For Axis Bank Limited

 

 

Sandeep Poddar

Company Secretary

CC: 

London Stock Exchange

Singapore Stock Exchange

 

 

 

Annexure A

 

Sr. No.

Particulars

Grant under Axis Bank Employees Stock Option Scheme 2000-01

(a)

Brief details of options/units granted

1,37,575 options.

(b)

Whether the scheme is in terms of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

Yes

(c)

Total number of shares covered by these options/units

1,37,575 equity shares of Rs. 2/- each of the Bank.

(d)

Pricing Formula

Granted at the latest available closing price prevailing on NSE being the Stock Exchange which recorded the highest trading volume in the equity shares of the Bank on July 15, 2025 i.e., being the previous trading day immediately preceding the date on which the grant of options was approved by the NRC.

(e)

Option Vested

The said options shall vest, as under:

- At the end of 1 year from the date of grant - 30% of granted options.

- At the end of 2 years from the date of grant - 30% of granted options.

- At the end of 3 years from the date of grant - 40% of granted options

(f)

Time within which option/units may be exercised

The said options can be exercised by the grantees, within a period of 5 years from the date of respective vesting.

 

 http://www.rns-pdf.londonstockexchange.com/rns/2977R_1-2025-7-16.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFISAMEISEDW
Date   Source Headline
28th Apr 202611:22 amRNSUpdate
28th Apr 202611:20 amRNSChange in SMP
28th Apr 202611:20 amRNSGeneral Update
28th Apr 202611:17 amRNSResults
28th Apr 202611:17 amRNSInvestor Presentation and Press Release
28th Apr 202611:16 amRNSDividend and Fund Raising
28th Apr 202611:13 amRNSAGM Update
4th Feb 202612:09 pmRNSMarket Rumour Verification
27th Jan 202610:48 amRNSOutcome of Board Meeting
26th Jan 20267:52 amRNSResults
19th Jan 20261:45 pmRNSResult of Postal Ballot
14th Jan 20269:55 amRNSGrant of Stock Options
29th Dec 20257:00 amRNSUpdate to the Global Medium Term Notes Programme
29th Dec 20257:00 amRNSUpdate to the Global Medium Term Notes Programme
19th Dec 20257:00 amRNSPostal Ballot Notice
19th Dec 20257:00 amRNSPostal Ballot Notice
18th Dec 20257:00 amRNSChange in Director
26th Nov 20251:32 pmRNSNCD Allotment
26th Nov 20251:13 pmRNSCHANGES IN SENIOR MANAGEMENT - CHIEF RISK OFFICER
26th Nov 20251:11 pmRNSNCD Issuance
15th Oct 20253:08 pmRNSGDR Policy
15th Oct 202511:38 amRNSResults
3rd Oct 20251:31 pmRNSPrior Intimation of Board Meeting
4th Aug 20257:00 amRNSDirectorate Change
25th Jul 20253:11 pmRNSPost AGM intimation
24th Jul 20254:04 pmRNSRevision in Vesting period
18th Jul 20259:18 amRNSChange in Management
17th Jul 202511:57 amRNSResults Q1FY26
16th Jul 20259:38 amRNSESOP Grant
2nd Jul 20252:03 pmRNSBoard Meeting Prior Intimation
27th Jun 20251:16 pmRNSPenalty
27th Jun 20257:25 amRNSBRSR
27th Jun 20257:24 amRNSNotice And Integrated Annual Report
5th Jun 20252:55 pmRNSChange in Director
2nd May 20254:17 pmRNSPostal Ballot Results and Scrutinizers Report
25th Apr 20251:52 pmRNSOutcome of Board Meeting
25th Apr 20251:49 pmRNSChange in Management
24th Apr 20252:25 pmRNSOutcome of Board Meeting
24th Apr 20252:23 pmRNSAnnual Financial Results FY25
15th Apr 20256:26 pmRNSPrior Intimation of Board Meeting
2nd Apr 202510:17 amRNSPostal Ballot Notice
13th Feb 202512:52 pmRNSChange in SMP
13th Feb 202512:49 pmRNSRBI Penalty
3rd Feb 20257:00 amRNSChange in vesting period
31st Jan 20252:24 pmRNSChange in Management
17th Jan 20252:46 pmRNSChange in Management
16th Jan 202511:02 amRNSMiscellaneous (Financial Results Q3FY25)
7th Jan 20257:00 amRNSIntimation of Board Meeting
27th Nov 20245:12 pmRNSIntimation wrt SEBI Interim Order Confirmatory
20th Nov 20247:00 amRNSRating Action by ICRA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.